Drug Shortage Report for REOPRO
Report ID | 45073 |
Drug Identification Number | 02216973 |
Brand name | REOPRO |
Common or Proper name | Abciximab |
Company Name | JANSSEN INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ABCIXIMAB |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1x5 |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-05-04 |
Actual start date | |
Estimated end date | 2019-12-31 |
Actual end date | 2018-06-14 |
Shortage status | Resolved |
Updated date | 2018-06-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 19 GREEN BELT DRIVE TORONTO, ONTARIO CANADA M3C 1L9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-06-15 | English | Compare |
v7 | 2018-06-14 | French | Compare |
v6 | 2018-06-14 | English | Compare |
v5 | 2018-05-05 | English | Compare |
v4 | 2018-05-04 | French | Compare |
v3 | 2018-05-04 | English | Compare |
v2 | 2018-04-05 | French | Compare |
v1 | 2018-04-05 | English | Compare |
Showing 1 to 8 of 8